Completed OBSERVATIONAL NCT04421183

Investigation of the Serum Mucoprotein 3 (MUC3) Protein Levels in Gestational Hypertensive Disease (MUC3)

Investigation of the Serum MUC3 Protein Levels in Gestational Hypertensive Disease (Preeclampsia-Eclampsia, Pregnancy Induced Hypertension, and HELLP Syndrome) Compared With Normal Pregnancy

Sponsor: Karadeniz Technical University

Conditions Muc3 Pregnancy Induced Hypertension

Interventions draw blood

Updated 5 times since 2020 Last updated: Jun 4, 2020 Started: Jun 1, 2010 Primary completion: Jan 1, 2011 Completion: Jan 2, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04421183, this observational or N/A phase trial focuses on Muc3 and Pregnancy Induced Hypertension and remains completed. Sponsored by Karadeniz Technical University, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2020 — Jan 2021 [monthly]

Completed

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karadeniz Technical University

Data source: Karadeniz Technical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Trabzon, Turkey (Türkiye)